← All organizations

Highest phase reached
Phase 4
First clinical trial
Sep 1, 2006Last known activity
Sep 30, 2024
Timeline
1990s
- Jan 1, 1996
Istituto Clinico Humanitas - Rozzano (MI), Italy— Founded
Drugs by trial phase (79 distinct, 57 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (48 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Adenoma
- Basal Cell Carcinoma
- Biliary Tract Neoplasms
- Body Weight
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cholangiocarcinoma
- Cholangitis
- Cholangitis, Sclerosing
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Coronavirus Infections
- Fatigue
- Fibrosis
- Hematologic Neoplasms
- Hepatic Insufficiency
- Hepatitis C
- Hodgkin Disease
- Infarction
- Infertility
- Infertility, Male
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Kidney Neoplasms
- Liver Cirrhosis
- Liver Failure
- Lung Neoplasms
- Lymphoma
- Mesothelioma
- Myocardial Infarction
- Neoplasms
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Neuroectodermal Tumors, Primitive, Peripheral
- Pancreatic Neoplasms
- POEMS Syndrome
- Reperfusion Injury
- Sarcoma
- Sarcoma, Ewing
- Severe Acute Respiratory Syndrome
- Small Cell Lung Carcinoma
- ST Elevation Myocardial Infarction
- Syndrome
- Thymoma
- Thymus Neoplasms
- Ulcer
Recent trials (50)
- NCT06258018Lead sponsorPhase 1/Phase 2Sep 30, 2024
- NCT06258018OfficialPhase 1/Phase 2Sep 30, 2024
- NCT06258018CollaboratorPhase 1/Phase 2Sep 30, 2024
- NCT06258018Sponsor investigatorPhase 1/Phase 2Sep 30, 2024
- NCT06918912Lead sponsorPhase 2Jun 16, 2023
- NCT05793489Lead sponsorN/AMar 6, 2023
- NCT05663060Lead sponsorN/ADec 13, 2022
- NCT06892223Lead sponsorPhase 2Dec 3, 2021
- NCT04722640Lead sponsorPhase 4Jan 25, 2021
- NCT04386070CollaboratorPhase 3May 15, 2020
- NCT04435977Overall official - principal investigatorPhase 2Jan 30, 2020
- NCT04435977Lead sponsorPhase 2Jan 30, 2020
- NCT05877040Lead sponsorPhase 2Jun 1, 2019
- NCT06325943Lead sponsorPhase 3Apr 1, 2019
- NCT03790189Study directorN/AJan 31, 2019
Details
- Founded
- Rozzano, IT Jan 1, 1996
- Last known activity
- Sep 30, 2024